½ÃÀ庸°í¼­
»óǰÄÚµå
1451331

¹ÙÀÌÅ» »çÀÎ ¸ð´ÏÅ͸µ ±â±â ½ÃÀå º¸°í¼­ : Á¦Ç° À¯Çü, ÃÖÁ¾»ç¿ëÀÚ, Áö¿ªº°(2024-2032³â)

Vital Signs Monitoring Devices Market Report by Product Type, End-User (Hospitals and Clinics, Ambulatory Surgery Centers, Home Care, and others), and Region 2024-2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: IMARC | ÆäÀÌÁö Á¤º¸: ¿µ¹® 148 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¹ÙÀÌÅ» »çÀÎ ¸ð´ÏÅ͸µ ±â±â ¼¼°è ½ÃÀå ±Ô¸ð´Â 2023³â 57¾ï ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù. ÇâÈÄ IMARC GroupÀº 2032³â±îÁö ½ÃÀå ±Ô¸ð°¡ 95¾ï ´Þ·¯¿¡ ´ÞÇϰí 2024-2032³â ¿¬Æò±Õ ¼ºÀå·ü(CAGR)Àº 5.6%¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøÇß½À´Ï´Ù. ÀÌ ½ÃÀåÀº ´ëÁßÀÇ °Ç°­ °ü¸®¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡, °¢Á¾ ÀÇ·á±â±âÀÇ ¼ÒÇüÈ­ ¹× °í¼º´ÉÈ­, ÀÇ·áÁø°ú ¿ø°ÝÀ¸·Î ¼ÒÅëÇÒ ¼ö ÀÖ´Â ¿ø°ÝÀÇ·á ¼­ºñ½º äÅà Ȯ´ë µîÀ» ¹è°æÀ¸·Î ²ÙÁØÇÑ ¼ºÀå¼¼¸¦ º¸À̰í ÀÖ½À´Ï´Ù.

¹ÙÀÌÅ» »çÀÎ ¸ð´ÏÅ͸µ ±â±â ½ÃÀå ºÐ¼®:

½ÃÀå ¼ºÀå°ú ±Ô¸ð : ¼¼°è ¹ÙÀÌÅ» »çÀÎ ¸ð´ÏÅ͸µ ±â±â ½ÃÀåÀº ¸¸¼ºÁúȯ À¯º´·ü Áõ°¡¿Í Àα¸ °í·ÉÈ­·Î ÀÎÇØ ¿Ï¸¸ÇÑ ¼ºÀå¼¼¸¦ º¸À̰í ÀÖ½À´Ï´Ù.

ÁÖ¿ä ½ÃÀå ÃËÁø¿äÀÎ : ÇコÄɾ ´ëÇÑ ÀÎ½Ä Áõ°¡, Á¤ºÎ ÀÌ´Ï¼ÅÆ¼ºê ¹× ÀÇ·á °³Çõ, ¿¹¹æ ÀÇ·á ¹× ºñ¿ë È¿À²ÀûÀÎ ÀÇ·á ¼­ºñ½º Á¦°øÀ» À§ÇÑ ¸ð´ÏÅ͸µ ±â±â äÅÃÀ» ÃËÁøÇÏ´Â °ÍÀÌ ÁÖ¿ä ¿äÀÎÀ¸·Î ²ÅÈü´Ï´Ù.

±â¼úÀÇ ¹ßÀü : Áö¼ÓÀûÀÎ ±â¼ú Çõ½ÅÀ¸·Î ÈÞ´ë°¡ °£ÆíÇÏ°í »ç¿ëÇϱ⠽¬¿ì¸ç ÀΰøÁö´É(AI)ÀÌ Å¾ÀçµÈ ¸ð´ÏÅ͸µ ±â±âÀÇ °³¹ßÀÌ ÁøÇàµÇ°í ÀÖ½À´Ï´Ù. ƯÈ÷ ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ ±â´ÉÀº ¿ø°ÝÀÇ·áÀÇ È®ÀåÀ» À§ÇØ Á¡Á¡ ´õ Áß¿äÇØÁö°í ÀÖ½À´Ï´Ù.

»ê¾÷¿ë : ¹ÙÀÌÅ» »çÀÎ ¸ð´ÏÅ͸µ ±â±â´Â º´¿ø, ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ(ASC), ÀçÅà ÀÇ·á ȯ°æ, ¿ø°ÝÀÇ·á ¼­ºñ½º µî ´Ù¾çÇÑ ÀÇ·á ¼­ºñ½º ºÐ¾ß¿¡ Àû¿ëµÇ°í ÀÖ½À´Ï´Ù.

ÁÖ¿ä ½ÃÀå µ¿Çâ : ¿ø°ÝÀÇ·á¿Í ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µÀÌ °¢±¤¹Þ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ±ÔÁ¦ Áؼö¿Í ȯÀÚ Á᫐ ÀÇ·á°¡ ±â±â °³¹ß¿¡ ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù.

Áö¿ªº° µ¿Çâ : ÀÇ·áºñ »ó½Â°ú ±â¼ú ¹ßÀüÀ¸·Î ÀÎÇØ ºÏ¹Ì°¡ ½ÃÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù. ±×·¯³ª ¾Æ½Ã¾ÆÅÂÆò¾çÀº ÀÇ·á ¼­ºñ½º Á¢±Ù¼ºÀ» È®´ëÇϱâ À§ÇÑ Á¤ºÎÀÇ ³ë·ÂÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ±Þ¼ºÀåÇÏ´Â ½ÃÀåÀ¸·Î ºÎ»óÇϰí ÀÖ½À´Ï´Ù.

°æÀï ȯ°æ : ½ÃÀåÀÇ ÁÖ¿ä ¾÷üµéÀº °æÀï·ÂÀ» À¯ÁöÇϱâ À§ÇØ ¿¬±¸°³¹ß(R&D), Àü·«Àû Á¦ÈÞ, Àμö, ¼¼°è ÁøÃâ¿¡ ÅõÀÚÇϰí ÀÖ½À´Ï´Ù. ±ÔÁ¦ Ç¥ÁØ ¹× ÀÎÁõ Áؼö´Â »óÀ§ ±â¾÷µé¿¡°Ô ¿ì¼±¼øÀ§°¡ µÇ°í ÀÖ½À´Ï´Ù.

µµÀü°ú ±âȸ : °æÀï ½ÉÈ­, º¹ÀâÇÑ ±ÔÁ¦ ȯ°æ ±Øº¹, µ¥ÀÌÅÍ ÇÁ¶óÀ̹ö½Ã ¿ì·Á¿¡ ´ëÇÑ ´ëÀÀ µîÀÌ µµÀü °úÁ¦ÀÔ´Ï´Ù. ÇÏÁö¸¸ ÀçÅà ¸ð´ÏÅ͸µ¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ ±â´É °­È­, ½ÅÈï ½ÃÀå ¼ö¿ä¿¡ ´ëÇÑ ´ëÀÀ µîÀÇ ±âȸ°¡ ÀÌ·¯ÇÑ °úÁ¦¸¦ ±Øº¹ÇÒ ¼ö ÀÖ´Â ±âȸ·Î ÀÛ¿ëÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¹ÙÀÌÅ» »çÀÎ ¸ð´ÏÅ͸µ ±â±â ½ÃÀå µ¿Çâ:

°Ç°­°ü¸®¿¡ ´ëÇÑ ÀνÄÀÇ Áõ°¡¿Í °í·ÉÈ­

¼¼°è °í·ÉÈ­ Àα¸ÀÇ Áõ°¡´Â ½ÃÀå ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. °í·ÉÈ­·Î ÀÎÇØ ¸¸¼º Áúȯ°ú ³ëÈ­ °ü·Ã Áúº´¿¡ °É¸± È®·üÀÌ ³ô¾ÆÁö¸é¼­ Ç÷¾Ð, ½É¹Ú¼ö, ü¿Â µî »ýü ½ÅÈ£¿¡ ´ëÇÑ Áö¼ÓÀûÀÎ ¸ð´ÏÅ͸µÀÌ ÇÊ¿äÇØÁ³½À´Ï´Ù. ÀÌ·¯ÇÑ Àα¸ Åë°èÇÐÀû º¯È­´Â °Ç°­ ¹®Á¦ÀÇ Á¶±â ¹ß°ß°ú »çÀü °ü¸®ÀÇ Á߿伺¿¡ ´ëÇÑ ÀνÄÀÇ Áõ°¡·Î À̾îÁö°í ÀÖ½À´Ï´Ù. ÀÇ·á ¼­ºñ½º Á¦°øÀÚ¿Í °£º´ÀÎÀº Á¤±âÀûÀÎ ¸ð´ÏÅ͸µÀÌ Á¶±â °³ÀÔÀ¸·Î À̾îÁ® ÀÔ¿øÀ²°ú °ü·Ã ÀÇ·á ºñ¿ëÀ» ÁÙÀÏ ¼ö ÀÖ´Ù´Â °ÍÀ» ÀνÄÇϰí ÀÖ½À´Ï´Ù. ±× °á°ú, ÀÓ»ó ÇöÀå°ú °¡Á¤ ¸ðµÎ¿¡¼­ ¹ÙÀÌÅ» »çÀÎ ¸ð´ÏÅ͸µ ±â±â¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â±â´Â °³ÀÎÀÌ ÀÚ½ÅÀÇ °Ç°­À» °ü¸®ÇÒ ¼ö ÀÖ´Â ±ÇÇÑÀ» ºÎ¿©Çϰí, ÀÇ·á Àü¹®°¡¿¡°Ô Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» À§ÇÑ ±ÍÁßÇÑ µ¥ÀÌÅ͸¦ Á¦°øÇÕ´Ï´Ù. ¶ÇÇÑ, Àü ¼¼°è º´¿ø°ú ÀÇ·á ½Ã¼³Àº ƯÈ÷ ÁßȯÀÚ½Ç(ICU)¿¡¼­ ȯÀÚÀÇ È°·Â ¡Èĸ¦ Áö¼ÓÀûÀ¸·Î ¸ð´ÏÅ͸µÇϱâ À§ÇØ ÀÌ·¯ÇÑ ±â±â¿¡ ´ëÇÑ ÀÇÁ¸µµ°¡ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ÀÌ¿¡ µû¶ó ȯÀÚ¿Í °¡Á·µéÀÌ °¡Á¤ ȯ°æ¿¡¼­ ½±°Ô Á¶ÀÛÇÒ ¼ö ÀÖ´Â ÈÞ´ë¿ë, »ç¿ëÀÚ Ä£È­ÀûÀÎ ¸ð´ÏÅ͸µ ¼Ö·ç¼ÇÀÇ °³¹ßÀÌ È°¹ßÈ÷ ÁøÇàµÇ°í ÀÖ½À´Ï´Ù.

±â¼úÀÇ ¹ßÀü°ú ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ

Áö¼ÓÀûÀÎ ±â¼ú Çõ½ÅÀ¸·Î »ýü ½ÅÈ£ ¸ð´ÏÅ͸µ ±â±âÀÇ °³¹ßÀÌ °è¼ÓµÇ°í ÀÖ½À´Ï´Ù. ¼¾¼­ÀÇ ¼ÒÇüÈ­, ¹«¼± ¿¬°á, ¿ø°ÝÀÇ·áÀÇ ºÎ»óÀ¸·Î ÀÇ·á ¼­ºñ½º Á¦°ø ¹æ½ÄÀÌ º¯È­Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â±âµéÀº ÇöÀç ÀÇ·á Àü¹®°¡¿¡°Ô ½Ç½Ã°£ µ¥ÀÌÅÍ Àü¼ÛÀ» Á¦°øÇÏ¿© ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µÀ» °¡´ÉÇÏ°Ô Çϰí ÀÖ½À´Ï´Ù. ¿þ¾î·¯ºí ¹ÙÀÌÅ» »çÀÎ ¸ð´ÏÅ͸µ ±â±â´Â ȯÀÚ°¡ ÀÚ½ÅÀÇ °Ç°­ »óŸ¦ Áö¼ÓÀûÀ¸·Î ÃßÀûÇÒ ¼ö ÀÖµµ·Ï µµ¿ÍÁÖ¸ç Å« Àα⸦ ²ø°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â±â´Â ÀÇ·á ¼­ºñ½º Á¦°øÀÚ¿¡°Ô µ¥ÀÌÅ͸¦ Àü¼ÛÇÒ ¼ö ÀÖ¾î ÀÌ»ó ¡Èİ¡ ÀÖÀ» °æ¿ì ½Å¼ÓÇÑ °³ÀÔÀ» º¸ÀåÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ AI¿Í ¸Ó½Å·¯´×(ML) ¾Ë°í¸®ÁòÀÌ ÀÌ·¯ÇÑ ±â±â¿¡ ÅëÇÕµÇ¾î ¿¹Ãø ºÐ¼® ¹× Á¶±â °æº¸ ½Ã½ºÅÛÀ» Á¦°øÇϰí ÀÖ½À´Ï´Ù. ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µÀÇ µµÀÔÀº ÀÇ·á ½Ã¼³¿¡ ´ëÇÑ Á¢±Ù¼ºÀÌ Á¦ÇÑµÉ ¼ö ÀÖ´Â ³óÃÌ Áö¿ªÀ̳ª Àú°³¹ß Áö¿ª¿¡¼­ ƯÈ÷ Áß¿äÇØÁö°í ÀÖ½À´Ï´Ù. ÀÇ·á ¼­ºñ½º Á¦°øÀÚ´Â ¸Ö¸® ¶³¾îÁø °÷¿¡¼­ ȯÀÚÀÇ È°·Â ¡Èĸ¦ ¸ð´ÏÅ͸µÇÒ ¼ö ÀÖ¾î ÀÚÁÖ ¹æ¹®ÇØ¾ß ÇÒ Çʿ伺À» ÁÙÀÏ ¼ö ÀÖ½À´Ï´Ù.

Á¤ºÎÀÇ ³ë·Â°ú ÇコÄÉ¾î °³Çõ

°¢±¹ Á¤ºÎ ±â°üÀº ÀÇ·á ÀÎÇÁ¶ó¸¦ °³¼±Çϰí ÀÇ·á ¼­ºñ½º¿¡ ´ëÇÑ Á¢±Ù¼ºÀ» È®´ëÇϱâ À§ÇØ Á¡Á¡ ´õ ¸¹Àº ³ë·ÂÀ» ±â¿ïÀ̰í ÀÖ½À´Ï´Ù. ¿©±â¿¡´Â ´Ù¾çÇÑ ÀÇ·á ȯ°æ¿¡¼­ ¹ÙÀÌÅ» »çÀÎ ¸ð´ÏÅ͸µ ±â±âÀÇ »ç¿ëÀ» ÃËÁøÇÏ´Â ÀÌ´Ï¼ÅÆ¼ºê°¡ Æ÷ÇԵ˴ϴÙ. ÀϺΠÁö¿ª¿¡¼­´Â ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µÀÇ ºñ¿ëÀ» Ãæ´çÇϱâ À§ÇØ »óȯ Á¤Ã¥À» ¾÷µ¥ÀÌÆ®ÇÏ¿© ÀÇ·á ¼­ºñ½º Á¦°øÀÚ°¡ ÀÌ·¯ÇÑ ±â¼úÀ» Áø·á¿¡ ÅëÇÕÇÒ ¼ö ÀÖ´Â Àμ¾Æ¼ºê¸¦ Á¦°øÇϰí ÀÖ½À´Ï´Ù. ÀÇ·á °³Çõ°ú °¡Ä¡ ±â¹Ý ÀÇ·á ¸ðµ¨·ÎÀÇ Àüȯµµ ¹ÙÀÌÅ» »çÀÎ ¸ð´ÏÅ͸µ ±â±â ½ÃÀåÀÇ ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ÀÇ·á ±â°üµéÀº ȯÀÚ ¿¹Èĸ¦ °³¼±Çϰí ÀÇ·áºñ¸¦ Àý°¨Çϱâ À§ÇØ ¿¹¹æÀû Ä¡·á¿Í Á¶±â °³ÀÔÀ» Áß¿äÇÑ Àü·«À¸·Î ¹Þ¾ÆµéÀ̰í ÀÖ½À´Ï´Ù. Ȱ·Â¡ÈÄ ¸ð´ÏÅ͸µ Àåºñ´Â °Ç°­ ¹®Á¦¸¦ Á¶±â¿¡ ¹ß°ßÇϰí, º´¿ø ÀçÀÔ¿øÀ» ÁÙÀ̸ç, Àü¹ÝÀûÀΠȯÀÚ °ü¸®¸¦ °­È­ÇÔÀ¸·Î½á ÀÌ·¯ÇÑ ¸ñÇ¥¿¡ ¿Ïº®ÇÏ°Ô ºÎÇÕÇÕ´Ï´Ù. ¶ÇÇÑ, ¸¸¼º Áúȯ °ü¸® ¹× ÀÇ·á °ÝÂ÷ ÇØ¼Ò¸¦ ¸ñÀûÀ¸·Î ÇÏ´Â Á¤ºÎ Áö¿ø ÀÇ·á ÇÁ·Î±×·¥µµ Ȱ·Â¡ÈÄ ¸ð´ÏÅ͸µ ÀåºñÀÇ Ã¤ÅÃÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â±âµéÀº ȯÀÚ Âü¿©µµ¸¦ ³ôÀ̰í, Ä¡·áÀÇ ÁúÀ» Çâ»ó½Ã۸ç, ±Ã±ØÀûÀ¸·Î ´õ ³ªÀº ÀÇ·á °á°ú¸¦ ´Þ¼ºÇÏ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹üÀ§¿Í Á¶»ç ¹æ¹ý

  • Á¶»ç ¸ñÀû
  • ÀÌÇØ°ü°èÀÚ
  • µ¥ÀÌÅÍ ¼Ò½º
    • 1Â÷ Á¤º¸
    • 2Â÷ Á¤º¸
  • ½ÃÀå ÃßÁ¤
    • »óÇâ½Ä Á¢±Ù
    • ÇÏÇâ½Ä Á¢±Ù
  • Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ¼Ò°³

  • °³¿ä
  • ÁÖ¿ä »ê¾÷ µ¿Çâ

Á¦5Àå ¹ÙÀÌÅ» »çÀÎ ¸ð´ÏÅ͸µ ±â±â ¼¼°è ½ÃÀå

  • ½ÃÀå °³¿ä
  • ½ÃÀå ½ÇÀû
  • COVID-19ÀÇ ¿µÇâ
  • ½ÃÀå ¿¹Ãø

Á¦6Àå ½ÃÀå ³»¿ª : Á¦Ç° À¯Çüº°

  • BP ¸ð´ÏÅ͸µ ±â±â
    • ½ÃÀå µ¿Çâ
    • ÁÖ¿ä À¯Çü
      • ¾Æ³×·ÎÀ̵åÇü BP ¸ð´ÏÅÍ
      • ÀÚµ¿ Ç÷¾Ð°è
    • ½ÃÀå ¿¹Ãø
  • »ê¼ÒÆ÷È­µµÃøÁ¤±â
    • ½ÃÀå µ¿Çâ
    • ÁÖ¿ä Á¾·ù
      • Ź»óÇü/º£µå»çÀ̵åÇü »ê¼ÒÆ÷È­µµÃøÁ¤±â
      • ¼Õ°¡¶ôÇü
      • ÇÚµåÇïµåÇü
      • ¼Õ¸ñ ÀåÂøÇü
      • ¼Ò¾Æ¿ë »ê¼ÒÆ÷È­µµÃøÁ¤±â
    • ½ÃÀå ¿¹Ãø
  • ¿Âµµ ¸ð´ÏÅ͸µ ±â±â
    • ½ÃÀå µ¿Çâ
    • ÁÖ¿ä Á¾·ù
      • ¼öÀº ü¿Â°è
      • µðÁöÅÐ ¿Âµµ°è
      • Àû¿Ü¼± ¿Âµµ°è
      • ¿Âµµ ½ºÆ®¸³
    • ½ÃÀå ¿¹Ãø
  • ±âŸ
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø

Á¦7Àå ½ÃÀå ³»¿ª : ÃÖÁ¾»ç¿ëÀÚº°

  • º´¿ø¡¤Å¬¸®´Ð
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ(ASCs)
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • ÀçÅÃÀÇ·á
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • ±âŸ
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø

Á¦8Àå ½ÃÀå ³»¿ª : Áö¿ªº°

  • ºÏ¹Ì
    • ¹Ì±¹
      • ½ÃÀå µ¿Çâ
      • ½ÃÀå ¿¹Ãø
    • ij³ª´Ù
      • ½ÃÀå µ¿Çâ
      • ½ÃÀå ¿¹Ãø
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
      • ½ÃÀå µ¿Çâ
      • ½ÃÀå ¿¹Ãø
    • ÀϺ»
      • ½ÃÀå µ¿Çâ
      • ½ÃÀå ¿¹Ãø
    • Àεµ
      • ½ÃÀå µ¿Çâ
      • ½ÃÀå ¿¹Ãø
    • Çѱ¹
      • ½ÃÀå µ¿Çâ
      • ½ÃÀå ¿¹Ãø
    • È£ÁÖ
      • ½ÃÀå µ¿Çâ
      • ½ÃÀå ¿¹Ãø
    • Àεµ³×½Ã¾Æ
      • ½ÃÀå µ¿Çâ
      • ½ÃÀå ¿¹Ãø
    • ±âŸ
      • ½ÃÀå µ¿Çâ
      • ½ÃÀå ¿¹Ãø
  • À¯·´
    • µ¶ÀÏ
      • ½ÃÀå µ¿Çâ
      • ½ÃÀå ¿¹Ãø
    • ÇÁ¶û½º
      • ½ÃÀå µ¿Çâ
      • ½ÃÀå ¿¹Ãø
    • ¿µ±¹
      • ½ÃÀå µ¿Çâ
      • ½ÃÀå ¿¹Ãø
    • ÀÌÅ»¸®¾Æ
      • ½ÃÀå µ¿Çâ
      • ½ÃÀå ¿¹Ãø
    • ½ºÆäÀÎ
      • ½ÃÀå µ¿Çâ
      • ½ÃÀå ¿¹Ãø
    • ·¯½Ã¾Æ
      • ½ÃÀå µ¿Çâ
      • ½ÃÀå ¿¹Ãø
    • ±âŸ
      • ½ÃÀå µ¿Çâ
      • ½ÃÀå ¿¹Ãø
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
      • ½ÃÀå µ¿Çâ
      • ½ÃÀå ¿¹Ãø
    • ¸ß½ÃÄÚ
      • ½ÃÀå µ¿Çâ
      • ½ÃÀå ¿¹Ãø
    • ±âŸ
      • ½ÃÀå µ¿Çâ
      • ½ÃÀå ¿¹Ãø
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ³»¿ª : ±¹°¡º°
    • ½ÃÀå ¿¹Ãø

Á¦9Àå SWOT ºÐ¼®

  • °³¿ä
  • °­Á¡
  • ¾àÁ¡
  • ±âȸ
  • À§Çù

Á¦10Àå ¹ë·ùüÀÎ ºÐ¼®

Á¦11Àå Porter's Five Forces ºÐ¼®

  • °³¿ä
  • ±¸¸ÅÀÚÀÇ ±³¼··Â
  • °ø±Þ ±â¾÷ÀÇ ±³¼··Â
  • °æÀï Á¤µµ
  • ½Å±Ô Âü¿©¾÷üÀÇ À§Çù
  • ´ëüǰÀÇ À§Çù

Á¦12Àå °¡°Ý ºÐ¼®

Á¦13Àå °æÀï »óȲ

  • ½ÃÀå ±¸Á¶
  • ÁÖ¿ä ±â¾÷
  • ÁÖ¿ä ±â¾÷ °³¿ä
    • A&D Company Ltd.
    • Contec Medical Systems Co. Ltd.
    • GE Healthcare
    • Koninklijke Philips N.V.
    • Masimo
    • Medtronic
    • Nihon Kohden Corporation
    • Nonin Medical Inc.
    • Omron Healthcare Inc.
    • Smiths Group Plc
ksm 24.04.15

The global vital signs monitoring devices market size reached US$ 5.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 9.5 Billion by 2032, exhibiting a growth rate (CAGR) of 5.6% during 2024-2032. The market is experiencing steady growth driven by the increasing healthcare awareness among the masses, rising miniaturization and enhancement of various healthcare devices, and the growing adoption of telehealth services to communicate with healthcare providers remotely.

Vital Signs Monitoring Devices Market Analysis:

Market Growth and Size: The global vital signs monitoring devices market is experiencing moderate growth on account of the increasing prevalence of chronic diseases and the aging global population.

Major Market Drivers: Key factors include the rising healthcare awareness and government initiatives and healthcare reforms, which are supporting the adoption of monitoring devices for preventive care and cost-effective healthcare delivery.

Technological Advancements: Ongoing innovations are leading to the development of portable, user-friendly, and artificial intelligence (AI)-enhanced monitoring devices. Remote patient monitoring capabilities are becoming increasingly important, especially for telemedicine expansion.

Industry Applications: Vital signs monitoring devices find applications in hospitals, ambulatory surgery centers (ASCs), home care settings, and telehealth services, covering a wide spectrum of healthcare delivery.

Key Market Trends: Telemedicine and remote patient monitoring are gaining prominence. Moreover, regulatory compliance and patient-centric care are positively impacting device development.

Geographical Trends: North America dominates the market, driven by the high healthcare costs and technological advancements. However, Asia Pacific is emerging as a fast-growing market on account of the rising number of government initiatives to expand healthcare access.

Competitive Landscape: Key players in the market are investing in research and development (R&D), strategic partnerships, acquisitions, and global expansion to maintain competitiveness. Compliance with regulatory standards and certifications is considered a priority among top companies.

Challenges and Opportunities: Challenges include intense competition, navigating complex regulatory environments, and addressing data privacy concerns. Nonetheless, opportunities for meeting the increasing demand for home-based monitoring, further enhancing remote patient monitoring capabilities, and catering to emerging market needs are projected to overcome these challenges.

Vital Signs Monitoring Devices Market Trends:

Rising healthcare awareness and aging population

An increase in the aging population worldwide is impelling the growth of the market. As individuals age, they are more prone to chronic health conditions and age-related diseases, necessitating continuous monitoring of vital signs, such as blood pressure, heart rate, and temperature. This demographic shift is leading to a heightened awareness about the importance of early detection and proactive management of health issues. Healthcare providers and caregivers recognize that regular monitoring can lead to early intervention, potentially reducing hospitalization rates and the associated healthcare costs. As a result, there is an increase in the demand for vital signs monitoring devices, both in clinical settings and for home use. These devices empower individuals to take control of their health and provide healthcare professionals with valuable data for informed decision-making. Moreover, hospitals and healthcare facilities worldwide are increasingly relying on these devices to continuously monitor the vital signs of patients, especially in intensive care units (ICUs). This is also facilitating the development of portable and user-friendly monitoring solutions that can be easily operated by patients and their families in home environments.

Technological advancements and remote patient monitoring

Continuous innovations are leading to the development of vital signs monitoring devices. Miniaturization of sensors, wireless connectivity, and the rise of telemedicine are transforming the way healthcare is delivered. These devices now offer real-time data transmission to healthcare professionals, enabling remote patient monitoring. Wearable vital signs monitoring devices are gaining immense popularity, allowing patients to track their health status continuously. These devices can transmit data to healthcare providers, ensuring prompt intervention in case of any anomalies. Additionally, AI and machine learning (ML) algorithms are being integrated into these devices, providing predictive analytics and early warning systems. The adoption of remote patient monitoring is becoming especially crucial in rural and underdeveloped areas, where access to healthcare facilities may be limited. It enables healthcare providers to monitor the vital signs of patients from a distance, reducing the need for frequent in-person visits.

Government initiatives and healthcare reforms

Governing agencies of various countries are increasingly focusing on improving healthcare infrastructure and expanding access to healthcare services. This includes initiatives to promote the use of vital signs monitoring devices in various healthcare settings. In some regions, reimbursement policies are being updated to cover the costs of remote patient monitoring, incentivizing healthcare providers to integrate these technologies into their practices. Healthcare reforms and the shift towards value-based care models are also contributing to the growth of the vital signs monitoring devices market. Healthcare organizations are embracing preventive care and early intervention as key strategies to improve patient outcomes and reduce healthcare costs. Vital signs monitoring devices align perfectly with these goals by enabling the early detection of health issues, reducing hospital readmissions, and enhancing overall patient care. Furthermore, government-funded healthcare programs, such as those aimed at managing chronic diseases and reducing healthcare disparities, are driving the adoption of vital signs monitoring devices. These devices play a vital role in improving patient engagement, enhancing the quality of care, and ultimately achieving better healthcare outcomes.

Vital Signs Monitoring Devices Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on product type and end-user.

Breakup by Product Type:

BP Monitoring Devices

Aneroid BP Monitors

Automated BP Monitors

Pulse-Oximeters

Tabletop/Bedside Pulse-Oximeters

Fingertip

Handheld

Wrist Worn

Pediatric Pulse-Oximeters

Temperature Monitoring Devices

Mercury-Filled Thermometers

Digital Thermometers

Infrared Thermometers

Temperature Strips

Others

BP monitoring devices account for the majority of the market share

The report has provided a detailed breakup and analysis of the market based on the product type. This includes BP monitoring devices (aneroid BP monitors and automated BP monitors), pulse-oximeters (tabletop/bedside pulse-oximeters, fingertip, handheld, wrist worn, and pediatric pulse-oximeters), temperature monitoring devices (mercury-filled thermometers, digital thermometers, infrared thermometers, and temperature strips), and others. According to the report, BP monitoring devices represented the largest segment.

Blood pressure (BP) monitoring devices include both manual and automated blood pressure monitors, and they are widely used in clinical settings, hospitals, and homes to measure systolic and diastolic blood pressure. The primary factors driving the demand for various BP monitoring devices include the increasing prevalence of hypertension and cardiovascular diseases globally. Additionally, the aging population and growing awareness about the importance of blood pressure management are catalyzing the demand for these devices. Technological advancements, such as the development of compact and user-friendly blood pressure monitors, are further fueling their adoption in home healthcare settings.

Pulse oximeters are designed to measure the oxygen saturation level in the blood, as well as the pulse rate of a person. Pulse oximeters are crucial in monitoring respiratory conditions, such as chronic obstructive pulmonary disease (COPD) and asthma, as well as assessing the oxygen levels in patients with COVID-19. The convenience of handheld and fingertip pulse oximeters is contributing to their widespread use, both in clinical settings and for personal health monitoring.

Temperature monitoring devices include digital thermometers, infrared thermometers, and wearable temperature sensors. Temperature monitoring is a fundamental aspect of healthcare, as it helps in detecting fever, infections, and various illnesses. With the advent of non-contact infrared thermometers, temperature monitoring is becoming more convenient and hygienic.

Breakup by End-User:

Hospitals and Clinics

Ambulatory Surgery Centers (ASCs)

Home Care

Others

Hospitals and clinics hold the largest share in the industry

A detailed breakup and analysis of the market based on the end-user have also been provided in the report. This includes hospitals and clinics, ambulatory surgery centers (ASCs), home care, and others. According to the report, hospitals and clinics accounted for the largest market share.

Hospitals and clinics heavily rely on advanced monitoring equipment to provide comprehensive patient care. Vital signs monitoring devices, including BP monitors, pulse oximeters, and temperature monitoring devices, are essential tools in diagnosing and managing a wide range of medical conditions. In hospitals, these devices are used in various departments, such as emergency rooms, ICUs, operating rooms, and general patient wards. The continuous monitoring of vital signs is important for patient safety and effective treatment planning. The increasing number of hospital admissions, surgical procedures, and the demand for real-time patient data are driving the adoption of vital signs monitoring devices in healthcare facilities.

Ambulatory surgery centers (ASCs) are healthcare facilities that offer same-day surgical procedures without the need for overnight hospitalization. These centers require portable and efficient vital signs monitoring devices to ensure patient safety during surgical procedures and recovery. The increasing popularity of ASCs as a cost-effective and convenient option for outpatient surgeries is leading to the adoption of vital signs monitoring equipment in these settings.

The home care segment is driving the demand for vital signs monitoring devices due to the rising health awareness among the masses. Advances in technology are making it possible for patients to monitor their vital signs conveniently in the comfort of their homes. This segment includes individuals with chronic diseases, seniors, and those in need of long-term care. Vital signs monitoring devices, particularly BP monitors and digital thermometers are widely used in home care settings.

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America leads the market, accounting for the largest vital signs monitoring devices market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

The North America vital signs monitoring devices market is driven by the increasing development of advanced devices, including wearable monitors with artificial intelligence (AI) capabilities for real-time data analysis. Moreover, the high healthcare costs are driving the adoption of vital signs monitoring devices as a cost-effective way to manage chronic diseases and reduce hospital readmissions.

Asia Pacific maintains a strong presence due to the growing healthcare expenditure and greater accessibility to healthcare services, thus driving the demand for vital signs monitoring devices. Governing agencies in the region are implementing healthcare reforms and promoting the use of monitoring devices for remote patient care, contributing to market growth.

Europe stands as another key region in the market, owing to the increasing awareness about the importance of proactive healthcare management, coupled with an aging population. Manufacturers are focusing on compliance with regulations, leading to a market driven by reliable and certified devices.

Latin America has a growing presence in the vital signs monitoring devices market. It is fueled by the rising investments in healthcare infrastructure, particularly in remote and underserved areas. The increasing awareness about preventive healthcare is driving individuals to monitor their health more closely, leading to higher sales of home-based vital signs monitoring devices.

The Middle East and Africa region is currently experiencing growth. It can be attributed to the rising focus on improving and modernizing the healthcare systems and increasing adoption go of advanced medical devices like vital signs monitors in healthcare facilities.

Leading Key Players in the Vital Signs Monitoring Devices Industry:

The key players in the vital signs monitoring devices market are actively engaged in several strategic initiatives to maintain their competitive edge. These efforts include ongoing research and development (R&D) to introduce technologically advanced and innovative monitoring devices that offer real-time data analytics and remote connectivity, aligning with the growing demand for telehealth services. Additionally, major players are expanding their global footprint through strategic partnerships, acquisitions, and collaborations to penetrate emerging markets and strengthen their distribution networks. Furthermore, a focus on complying with regulatory standards and certifications remains paramount to ensure product quality and safety, as well as to gain the trust of healthcare professionals and end-users. Overall, leading companies are committed to addressing evolving healthcare needs and capitalizing on market opportunities.

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

A&D Company Ltd.

Contec Medical Systems Co. Ltd.

GE Healthcare

Koninklijke Philips N.V.

Masimo

Medtronic

Nihon Kohden Corporation

Nonin Medical Inc.

Omron Healthcare Inc.

Smiths Group Plc

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Latest News:

December 2021: A&D Company Ltd. announced its partnership with Smart Meter Corporation to develop and deliver top-quality remote patient monitoring (RPM) devices like clinically validated blood pressure monitors, weight scales, activity monitors, and other health monitoring devices, which use advanced cellular-enabled technology to best connect patients, caregivers, and healthcare providers.

August 2023: GE Healthcare announced that it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for its Portrait Mobile wireless and wearable monitoring solution, which enables real-time continuous monitoring with a personalized view of the vitals of patients while keeping them mobile during critical recovery periods, especially after surgery or discharge from the ICU.

Key Questions Answered in This Report

  • 1. What was the size of the global vital signs monitoring devices market in 2023?
  • 2. What is the expected growth rate of the global vital signs monitoring devices market during 2024-2032?
  • 3. What are the key factors driving the global vital signs monitoring devices market?
  • 4. What has been the impact of COVID-19 on the global vital signs monitoring devices market?
  • 5. What is the breakup of the global vital signs monitoring devices market based on the product type?
  • 6. What is the breakup of the global vital signs monitoring devices market based on the end-user?
  • 7. What are the key regions in the global vital signs monitoring devices market?
  • 8. Who are the key players/companies in the global vital signs monitoring devices market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Vital Signs Monitoring Devices Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 BP Monitoring Devices
    • 6.1.1 Market Trends
    • 6.1.2 Major Types
      • 6.1.2.1 Aneroid BP Monitors
      • 6.1.2.2 Automated BP Monitors
    • 6.1.3 Market Forecast
  • 6.2 Pulse-Oximeters
    • 6.2.1 Market Trends
    • 6.2.2 Major Types
      • 6.2.2.1 Tabletop/Bedside Pulse-Oximeters
      • 6.2.2.2 Fingertip
      • 6.2.2.3 Handheld
      • 6.2.2.4 Wrist Worn
      • 6.2.2.5 Pediatric Pulse-Oximeters
    • 6.2.3 Market Forecast
  • 6.3 Temperature Monitoring Devices
    • 6.3.1 Market Trends
    • 6.3.2 Major Types
      • 6.3.2.1 Mercury-Filled Thermometers
      • 6.3.2.2 Digital Thermometers
      • 6.3.2.3 Infrared Thermometers
      • 6.3.2.4 Temperature Strips
    • 6.3.3 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by End-User

  • 7.1 Hospitals and Clinics
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Ambulatory Surgery Centers (ASCs)
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Home Care
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weaknesses
  • 9.4 Opportunities
  • 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 A&D Company Ltd.
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
    • 13.3.2 Contec Medical Systems Co. Ltd.
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
    • 13.3.3 GE Healthcare
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
    • 13.3.4 Koninklijke Philips N.V.
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
      • 13.3.4.3 Financials
      • 13.3.4.4 SWOT Analysis
    • 13.3.5 Masimo
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
      • 13.3.5.3 Financials
      • 13.3.5.4 SWOT Analysis
    • 13.3.6 Medtronic
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
      • 13.3.6.3 Financials
      • 13.3.6.4 SWOT Analysis
    • 13.3.7 Nihon Kohden Corporation
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
      • 13.3.7.3 Financials
      • 13.3.7.4 SWOT Analysis
    • 13.3.8 Nonin Medical Inc.
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
    • 13.3.9 Omron Healthcare Inc.
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
      • 13.3.9.3 SWOT Analysis
    • 13.3.10 Smiths Group Plc
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio
      • 13.3.10.3 Financials
      • 13.3.10.4 SWOT Analysis
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦